Advertisement
The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

FDA Approves Strativa Pharmaceuticals' Zuplenz® (ondansetron) Oral Soluble Film

July 2, 2010 8:36 pm | by Bio-Medicine.Org | News | Comments

WOODCLIFF LAKE, N.J. , July 2 /- Strativa Pharmaceuticals today announced that the U.S. Food and Drug Administration (FDA) has approved Zuplenz® (ondansetron) oral soluble film for the prevention of postoperative, highly and moderately emetogenic cancer chemotherapy-induced, and...

TOPICS:

Cepheid Xpert MRSA-SA Blood Culture Assay for Use with the GeneXpert Dx System: Class I Recall

July 2, 2010 8:31 pm | by U.S. Food & Drug Administration | News | Comments

The firm received increasing numbers of complaints for false negative MRSA results. False negative could result in incorrect treatment or delay of care for patients with MRSA infection.

TOPICS:

Wallabies and bats harbor 'fossil' genes from the most deadly family of human viruses

July 2, 2010 11:38 am | by EurekAlert | News | Comments

(University at Buffalo) Modern marsupials may be popular animals at the zoo and in children's books, but new findings by University at Buffalo biologists reveal that they harbor a "fossil" copy of a gene that codes for filoviruses, which cause Ebola and Marburg hemorrhagic fevers...

TOPICS:
Advertisement

Yale Researchers win $3.5M for Hepatitis C study

July 2, 2010 11:37 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Yale University researchers have received a $3.5 million grant from the National Institutes of Health to fund a study of hepatitis C virus. a deadly pathogen that attacks the liver and afflicts about 170 million people worldwide.

MiMedx Group, Inc. Announces Release Date for Second Quarter Results

July 2, 2010 11:36 am | by Bio-Medicine.Org | News | Comments

MARIETTA, Ga. , July 2 /- MiMedx Group, Inc. (OTC Bulletin Board: MDXG), an integrated developer, manufacturer and marketer of patent protected biomaterial-based products, announced today that its results for the second quarter, ended June 30, 2010 , will be released before the opening of...

TOPICS:

Watson Completes Acquisition of CRINONE® and PROCHIEVE® Product Line and Shares of Columbia Laboratories

July 2, 2010 11:36 am | by Bio-Medicine.Org | News | Comments

MORRISTOWN, N.J. , July 2 /- Watson Pharmaceuticals, Inc. (NYSE: WPI ) today completed the acquisition of the U.S. rights to Columbia Laboratories' CRINONE® and PROCHIEVE® progesterone gel product line and 11,200,000 shares of Columbia common stock. "We are pleased to add...

TOPICS:

LIFEPAK 20 and LIFEPAK 20e External Defibrillator/Monitors by Physio-Control Inc.: Class I Recall Due To Power Supply Failure(2)

July 2, 2010 11:31 am | by U.S. Food & Drug Administration | News | Comments

A power supply assembly failure can result in the inability to deliver defibrillation therapy.

TOPICS:

LIFEPAK 20 and LIFEPAK 20e External Defibrillator/Monitors by Physio-Control Inc.: Class I Recall Due To Power Supply Failure

July 2, 2010 11:30 am | News | Comments

A power supply assembly failure can result in the inability to deliver defibrillation therapy.

Advertisement

Micrus replacing CKE on S & P SmallCap 600

July 2, 2010 8:45 am | by The Associated Press | News | Comments

Standard & Poor's said Friday that medical device maker Micrus Endovascular Corp. will replace CKE Restaurants Inc. in the S&P SmallCap 600 index after the close of trading on July 7.CKE Restaurants is being acquired by affiliates of Apollo Management in a deal expected to close on or about...

EEOC sues company over harassment in Wis. store

July 2, 2010 7:45 am | by The Associated Press | News | Comments

A federal agency is accusing a Kentucky company of permitting a sexually hostile work environment in one of its Wisconsin pharmacies.The U.S. Equal Employment Opportunity Commission said Thursday it has filed a federal lawsuit. The suit names Covington, Ky.-based Omnicare Inc., which does...

Wellcome-Wolfson partnership makes £30 million investment in UK scientific infrastructure

July 2, 2010 7:35 am | by EurekAlert | News | Comments

(Wellcome Trust) Over £30 ($45) million is being invested into large-scale university infrastructure projects courtesy of the Wellcome-Wolfson Capital Awards initiative. The scheme is intended to facilitate internationally competitive, leading-edge biomedical research in a way that...

TOPICS:

Announcing launch of FRAX version 3.1

July 2, 2010 7:35 am | by EurekAlert | News | Comments

(International Osteoporosis Foundation) The newly released FRAX version 3.1 now includes country models for Australia, Canada, Chinese Taipei (Taiwan), Colombia, Hungary, Mexico, the Netherlands and South Korea. The tool is available in six additional languages.

TOPICS:

Class I Medical Device Recall: Physio-Control Inc., LIFEPAK 20 and LIFEPAK 20e External Defibrillator and Monitors

July 2, 2010 7:35 am | by U.S. Food & Drug Administration | News | Comments

A failure on the power supply assembly can result in either "No DC power" or "No DC or AC power". A failure of DC (battery) power can result in the inability to deliver defibrillation therapy if the device will not turn on using DC (battery) power and...

Biotech startup Alnara to be acquired by Eli Lilly

July 2, 2010 7:34 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Cambridge biotech Alnara Pharmaceuticals Inc. has agreed to be acquired by Eli Lilly and Company, bringing the Indianapolis pharmaceutical giant an inroad into enzyme replacement therapy, used to treat diseases such as cystic fibrosis.

Spina bifida topic of monthly genetics series

July 2, 2010 7:32 am | by Baylor College of Medicine | News | Comments

Spina bifida, a birth defect that involves the incomplete development of the spinal cord, will be the topic of discussion in a public forum Wednesday, July 14, at The Health Museum of Houston . The forum will feature Dr. Daryl Scott, assistant professor of molecular and human genetics at...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading